Details for Patent: RE38115

✉ Email this page to a colleague

Summary for Patent: RE38115

Title:	Dextromethorphan and an oxidase inhibitor for treating intractable conditions
Abstract:	Methods are disclosed for increasing the effectiveness of dextromethorphan in treating chronic or intractable pain, for treating tinnitus and for treating sexual dysfunction comprising administering dextromethorphan in combination with a therapeutically effective dosage of a debrisoquin hydroxylase inhibitor. A preferred combination is dextromethorphan and the oxidative inhibitor quinidine.
Inventor(s):	Smith; Richard Alan (La Jolla, CA), Licht; Jonathan M. (San Diego, CA)
Assignee:	Center for Neurologic Study (La Jolla, CA)
Application Number:	10/052,698
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent RE38115
Patent Claim Types: see list of patent claims	Use; Formulation; Dosage form;

Drugs Protected by US Patent RE38115

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: RE38115

PCT Information
PCT Filed	September 22, 1994	PCT Application Number:	PCT/US94/10771
PCT Publication Date:	March 28, 1996	PCT Publication Number:	WO96/09044

International Family Members for US Patent RE38115

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	8071894	⤷ Sign Up
Germany	69434794	⤷ Sign Up
European Patent Office	0788359	⤷ Sign Up
European Patent Office	1634597	⤷ Sign Up
Spain	2268686	⤷ Sign Up
Japan	4097285	⤷ Sign Up
Japan	H10505864	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.